Prior Coronary Artery Bypass Graft Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

JACC: Cardiovascular Interventions

Volumn 3, Issue 3, 2010, Pages 343-351

  Welsh, Robert C ^a   Granger, Christopher B ^b   Westerhout, Cynthia M ^a   Blankenship, James C ^c   Holmes Jr , David R ^d   O'Neill, William W ^e   Hamm, Christian W ^f   Van de Werf, Frans ^g   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f KERCKHOFF HEART CENTER   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

coronary artery bypass graft; percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

PEXELIZUMAB; PLACEBO;

ADULT; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SINGLE-CHAIN ANTIBODIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949337757     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.12.008     Document Type: Article

References (15)

1. Bourassa M.G., Fisher L.D., Campeau L., Gillespie M.J., McConney M., and Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 72 (1985) V71-V78
2. FitzGibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., and Burton J.R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616-626
3. Goldman S., Copeland J., Moritz T., et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation 80 (1989) 1190-1197
4. Goldman S., Copeland J., Moritz T., et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 89 (1994) 1138-1143
5. Goldman S., Zadina K., Krasnicka B., et al. Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297. J Am Coll Cardiol 29 (1997) 1563-1568
6. Labinaz M., Sketch Jr. M.H., Ellis S.G., et al. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J 141 (2001) 469-477
7. Grines C.L., Booth D.C., Nissen S.E., et al. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol 65 (1990) 1292-1296
8. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) E1-E211
9. Antman E.M., Hand M., Armstrong P.W., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (erratum in J Am Coll Cardiol 2008;51:977). J Am Coll Cardiol 51 (2008) 210-247
10. Armstrong P.W., Adams P.X., Al-Khalidi H.R., et al. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 149 (2005) 402-407
11. Mathew V., Gersh B., Barron H., et al. Inhospital outcome of acute myocardial infarction in patients with prior coronary artery bypass surgery. Am Heart J 144 (2002) 463-469
12. Peterson L.R., Chandra N.C., French W.J., Rogers W.J., Weaver W.D., and Tiefenbrunn A.J. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2). Am J Cardiol 84 (1999) 1287-1291
13. Stone G.W., Brodie B.R., Griffin J.J., et al. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. J Am Coll Cardiol 35 (2000) 605-611
14. Nguyen T.T., O'Neill W.W., Grines C.L., et al. One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. Am J Cardiol 91 (2003) 1250-1254
15. Al Suwaidi J., Velianou J.L., Berger P.B., et al. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J 142 (2001) 452-459